Cover ImageSALE
Market Research Report

Drug Eluting Stent Market in China - Industry Research Report 2015-2019

Published by TechNavio (Infiniti Research Ltd.) Product code 341722
Published Content info 56 Pages
Delivery time: 1-2 business days
Back to Top
Drug Eluting Stent Market in China - Industry Research Report 2015-2019
Published: October 7, 2015 Content info: 56 Pages

About drug eluting stent

Drug eluting stent, also known as medicated coronary stent, is a tiny, expandable metal mesh tube that is covered with a pharmacologic agent. It prevents artery blockages in patients after angioplasty. It also eliminates the need for repeated revascularization procedures that are used to treat restenosis (narrowing of blood vessels).

Technavio's analysts forecast the drug eluting stent market in China to grow at a CAGR of 10.70% over the period 2014-2019.

Covered in this report

This report covers the present and future scenario of the drug eluting stent market in China for the period 2015-2019. To calculate the market size, Technavio uses revenue generated from the sales of drug eluting stents.

Technavio's report, Drug Eluting Stent Market in China 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the drug eluting stent market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Vascular
  • Lepu Medical
  • Medtronic
  • MicroPort Scientific
  • Shandong JW Medical Systems

Other Prominent Vendors

  • Biosensors International
  • Boston Scientific
  • Cook Medical
  • Opto Circuit
  • QualiMed
  • Sinomed
  • Terumo Medical

Market driver

  • High prevalence of CVDs
  • For a full, detailed list, view our report

Market challenge

  • Availability of alternative coronary stents
  • For a full, detailed list, view our report

Market trend

  • Increase in demand for minimally-invasive procedures
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Table of Contents
Product Code: IRTNTR7180

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Stents: An overview

  • Stents

PART 06: Market landscape

  • Market overview
  • Five force analysis

PART 07: Healthcare reform in China

PART 08: Opportunities for global and local vendors

  • Local vendors
  • Global vendors

PART 09: Market drivers

  • High prevalence of CVDs
  • Advances in technology
  • Favorable reimbursement policies
  • Low risk of contracting restenosis

PART 10: Impact of drivers

PART 11: Market challenges

  • Availability of alternative coronary stents
  • Limitations of drug-eluting stents
  • Stringent regulations for device approval
  • Preference for drugs over stents

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Increased demand for minimally invasive procedures
  • Government support for local manufacturers
  • Growing popularity of hybrid procedures
  • Popularity of medical tourism

PART 14: Vendor landscape

  • Competitive scenario
  • Major vendor analysis 2014
  • Other prominent vendors

PART 15: Key vendor analysis

  • MicroPort
  • Lepu Medical Technology
  • JW Medical Systems
  • Abbott Vascular
  • Medtronic
  • Business overview

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Cross-sectional view of a stent with drug-loaded polymeric coating
  • Exhibit 03: Some agents used in drug eluting stents
  • Exhibit 04: Brief history of stents
  • Exhibit 05: Drug eluting stent market in China 2014-2019 ($ millions)
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Disease mortality in China 2014
  • Exhibit 08: Healthcare reforms in China
  • Exhibit 09: Number of medical institutes in China until 2012
  • Exhibit 10: Impact of drivers
  • Exhibit 11: Impact of drivers and challenges
  • Exhibit 12: Market share analysis of vendors
  • Exhibit 13: Microport Medical: Key takeaways
  • Exhibit 14: Lepu Medical: Key takeaways
  • Exhibit 15: Shandong JW Medical System: Key takeaways
  • Exhibit 16: Abbott Vascular: Key takeaways
  • Exhibit 17: Medtronic: Key takeaways
  • Exhibit 18: Microport: Business segmentation 2014 by revenue
  • Exhibit 19: MicroPort: Business segmentation by revenue 2013 and 2014 ($ millions)
  • Exhibit 20: Lepu Medical Technology: Product segmentation
  • Exhibit 21: Lepu Medical Technology: Revenue breakup 2014
  • Exhibit 22: JW Medical Systems: Product portfolio
  • Exhibit 23: Abbott Vascular: Product categories
Back to Top